-
and curious Postdoctoral Fellow to develop and drive projects on retinal disease modeling and repair. OPTI is a part of Genentech Research and Early Development (gRED): scientists in gRED
-
models to predict TCR-peptide/MHC (pMHC) interactions. Utilizing structural computational biology techniques to characterize and model TCR-pMHC interactions. Designing experiments to test and validate
-
at Genentech (gCS). The group develops and applies state-of-the-art ML/AI models to address open questions in genome biology, with the goal of understanding causal mechanisms of disease and facilitating drug
-
on developing and applying foundational AI models to investigate clinically relevant cancer vulnerabilities and their relationship with molecular context. Spanning functional genomics and large-scale clinical
-
apply cutting-edge machine learning algorithms, with focus on foundation models and LLMs/agents, to analyze complex biological data. This data includes gsingle cell genomics profiles, spatial data, and